Astrazeneca (AZN) Free Cash Flow Growth (3y) (2012 - 2026)
Analysis
Astrazeneca (AZN) Free Cash Flow Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Asml Holding | 618.78 Bn | 602.80 Bn | 5.90 Bn | - |
| 2 | Hsbc Holdings | 362.62 Bn | 362.62 Bn | - | - |
| 3 | General Electric | 329.79 Bn | 320.45 Bn | 6.95 Bn | 19.08% |
| 4 | Astrazeneca | 253.78 Bn | 248.49 Bn | 12.86 Bn | 22.20% |
| 5 | Citigroup | 228.38 Bn | -2,073.93 Bn | 24.75 Bn | - |
| 6 | Bhp | 216.07 Bn | 197.52 Bn | - | - |
| 7 | Rio Tinto | 203.71 Bn | 199.33 Bn | - | - |
| 8 | Diageo | 197.09 Bn | 195.06 Bn | - | - |
| 9 | Unilever | 139.31 Bn | 132.28 Bn | - | - |
| 10 | Hdfc Bank | 117.84 Bn | 80.69 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22.20% |
| Mar 31, 2026 | 4.94% |
| Dec 31, 2025 | -23.04% |
| Jun 30, 2025 | 39.16% |
| Mar 31, 2025 | 6.27% |
| Dec 31, 2024 | 27.58% |
| Sep 30, 2024 | 24.29% |
| Jun 30, 2024 | 43.23% |
| Mar 31, 2024 | 10.46% |
| Dec 31, 2023 | 54.47% |
| Jun 30, 2023 | 17.55% |
| Mar 31, 2023 | 118.28% |
| Dec 31, 2022 | 109.06% |
| Jun 30, 2022 | 78.03% |
| Mar 31, 2022 | 163.05% |
| Dec 31, 2021 | -11.82% |
| Sep 30, 2021 | 40.67% |
| Jun 30, 2021 | 51.70% |
| Mar 31, 2021 | 209.01% |
| Dec 31, 2020 | 13.60% |